Références

Ci-dessous les références de l’article de Jean-Daniel Lelièvre sur l’approche One Health en vaccination.

Par Jean-Daniel Lelièvre, Coordinateur DIM One Health 2.0
  1. Lynn, David J., Saoirse C. Benson, Miriam A. Lynn, et Bali Pulendran. «Modulation of Immune Responses to Vaccination by the Microbiota: Implications and Potential Mechanisms». Nature Reviews Immunology 22, no 1 (janvier 2022): 33-46. https://doi.org/10.1038/s41577-021-00554-7.
  2. Trinh, Pauline, Jesse R. Zaneveld, Sarah Safranek, et Peter M. Rabinowitz. «One Health Relationships Between Human, Animal, and Environmental Microbiomes: A Mini-Review». Frontiers in Public Health 6 (30 août 2018): 235. https://doi.org/10.3389/fpubh.2018.00235.
  3. Selter, Felicitas, et Sabine Salloch. «Whose Health and Which Health? Two Theoretical Flaws in the One Health Paradigm». Bioethics 37, no 7 (septembre 2023): 674-82. https://doi.org/10.1111/bioe.13192.
  4. https://www.visualcapitalist.com/all-the-biomass-of-earth-in-one-graphic/
  5. https://ourworldindata.org/wild-mammals-birds-biomass
  6. https://nielseniq.com/global/en/insights/report/2016/mans-best-friend-global-pet-ownership-and-feeding-trends/
  7. Draper, Simon J., et Jonathan L. Heeney. «Viruses as Vaccine Vectors for Infectious Diseases and Cancer». Nature Reviews Microbiology 8, no 1 (janvier 2010): 62-73. https://doi.org/10.1038/nrmicro2240.
  8. Paillot, Romain, Christel Marcillaud Pitel, Xavier D’Ablon, et Stéphane Pronost. «Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims». Vaccines 5, no 4 (4 décembre 2017): 46. https://doi.org/10.3390/vaccines5040046.
  9. Warimwe, George M., Michael J. Francis, Thomas A. Bowden, Samuel M. Thumbi, et Bryan Charleston. «Using Cross-Species Vaccination Approaches to Counter Emerging Infectious Diseases». Nature Reviews Immunology 21, no 12 (décembre 2021): 815-22. https://doi.org/10.1038/s41577-021-00567-2.
  10. https://www.woah.org/app/uploads/2021/06/plan-daction-mondial-contre-la-peste-bovine-2018.pdf
  11. https://www.weforum.org/stories/2022/07/zoonotic-disease-virus-covid/
  12. Chomel, B.B. «Zoonoses». In Encyclopedia of Microbiology, 820-29. Elsevier, 2009. https://doi.org/10.1016/B978-012373944-5.00213-3.
  13. Messenger, Ali M., Amber N. Barnes, et Gregory C. Gray. «Reverse Zoonotic Disease Transmission (Zooanthroponosis): A Systematic Review of Seldom-Documented Human Biological Threats to Animals». Édité par Bradley S. Schneider. PLoS ONE 9, no 2 (28 février 2014): e89055. https://doi.org/10.1371/journal.pone.0089055.
  14. Ash, A., A. Lymbery, J. Lemon, S. Vitali, et R.C.A. Thompson. «Molecular Epidemiology of Giardia Duodenalis in an Endangered Carnivore – The African Painted Dog». Veterinary Parasitology 174, no 3-4 (décembre 2010): 206-12. https://doi.org/10.1016/j.vetpar.2010.08.034.
  15. Nelson, Martha I., et Amy L. Vincent. «Reverse Zoonosis of Influenza to Swine: New Perspectives on the Human–Animal Interface». Trends in Microbiology 23, no 3 (mars 2015): 142-53. https://doi.org/10.1016/j.tim.2014.12.002.
  16. Ewers, Christa, Mirjam Grobbel, Ivonne Stamm, Peter A. Kopp, Ines Diehl, Torsten Semmler, Angelika Fruth, et al. «Emergence of Human Pandemic O25:H4-ST131 CTX-M-15 Extended-Spectrum-β-Lactamase-Producing Escherichia Coli among Companion Animals». Journal of Antimicrobial Chemotherapy 65, no 4 (avril 2010): 651-60. https://doi.org/10.1093/jac/dkq004.
  17. Krammer, Florian, Enikö Hermann, et Angela L. Rasmussen. «Highly Pathogenic Avian Influenza H5N1: History, Current Situation, and Outlook». Édité par Herman W. Favoreel. Journal of Virology, 27 mars 2025, e02209-24. https://doi.org/10.1128/jvi.02209-24.
  18. Peacock, Thomas P., Louise Moncla, Gytis Dudas, David VanInsberghe, Ksenia Sukhova, James O. Lloyd-Smith, Michael Worobey, Anice C. Lowen, et Martha I. Nelson. «The Global H5N1 Influenza Panzootic in Mammals». Nature 637, no 8045 (9 janvier 2025): 304-13. https://doi.org/10.1038/s41586-024-08054-z.
  19. https://openknowledge.fao.org/items/7c07dfba-99a6-4a1c-8218-94156527f405
  20. Poetri, Okti Nadia, Michiel Van Boven, Ivo Claassen, Guus Koch, I.Wayan Wibawan, Arjan Stegeman, Jan Van Den Broek, et Annemarie Bouma. «Silent Spread of Highly Pathogenic Avian Influenza H5N1 Virus amongst Vaccinated Commercial Layers». Research in Veterinary Science 97, no 3 (décembre 2014): 637-41. https://doi.org/10.1016/j.rvsc.2014.09.013.
  21. Cattoli, Giovanni, Alice Fusaro, Isabella Monne, Fethiye Coven, Tony Joannis, Hatem S. Abd El-Hamid, Aly Ahmed Hussein, et al. «Evidence for Differing Evolutionary Dynamics of A/H5N1 Viruses among Countries Applying or Not Applying Avian Influenza Vaccination in Poultry». Vaccine 29, no 50 (novembre 2011): 9368-75. https://doi.org/10.1016/j.vaccine.2011.09.127.
  22. Vergne, Timothée, Vladimir Grosbois, Yilma Jobre, Ahmed Saad, Amira Abd El Nabi, Shereen Galal, Mohamed Kalifa, et al. «Avian Influenza Vaccination of Poultry and Passive Case Reporting, Egypt». Emerging Infectious Diseases 18, no 12 (décembre 2012): 2076-78. https://doi.org/10.3201/eid1812.120616.
  23. Pongcharoensuk, P., W. Adisasmito, L. M. Sat, P. Silkavute, L. Muchlisoh, P. Cong Hoat, et R. Coker. «Avian and Pandemic Human Influenza Policy in South-East Asia: The Interface between Economic and Public Health Imperatives». Health Policy and Planning 27, no 5 (1 août 2012): 374-83. https://doi.org/10.1093/heapol/czr056.
  24. Zeng, Xianying, Guobin Tian, Jianzhong Shi, Guohua Deng, Chengjun Li, et Hualan Chen. «Vaccination of Poultry Successfully Eliminated Human Infection with H7N9 Virus in China». Science China Life Sciences 61, no 12 (décembre 2018): 1465-73. https://doi.org/10.1007/s11427-018-9420-1.
  25. Zou, Lin, Chong Zhang, Jianming Zhang, Jianguo Wang, Ling Tong, Lu Xi, Xiao Liu, et al. «Surveillance of H7N9 Avian Influenza Virus in Farmers’ Markets in Beijing in 2019–2023». One Health Advances 3, no 1 (20 février 2025): 3. https://doi.org/10.1186/s44280-025-00069-z.
  26. Cattoli, Giovanni, Alice Fusaro, Isabella Monne, Fethiye Coven, Tony Joannis, Hatem S. Abd El-Hamid, Aly Ahmed Hussein, et al. «Evidence for Differing Evolutionary Dynamics of A/H5N1 Viruses among Countries Applying or Not Applying Avian Influenza Vaccination in Poultry». Vaccine 29, no 50 (novembre 2011): 9368-75. https://doi.org/10.1016/j.vaccine.2011.09.127.
  27. https://agriculture.gouv.fr/tout-ce-quil-faut-savoir-sur-le-plan-daction-vaccination-iahp-en-france
  28. EFSA Panel on Animal Health and Animal Welfare (AHAW), ECDC, Julio Alvarez, Anette Boklund, Sabine Dippel, Fernanda Dórea, Jordi Figuerola, et al. «Preparedness, Prevention and Control Related to Zoonotic Avian Influenza». EFSA Journal 23, no 1 (janvier 2025). https://doi.org/10.2903/j.efsa.2025.9191.
  29. https://cdn.who.int/media/docs/default-source/consultation-rdb/2.licensed-and-stockpiled-vaccines.pdf?sfvrsn=845c87b2_3des H5 R&D.pptx
  30. Lembo, Tiziana, Katie Hampson, Magai T. Kaare, Eblate Ernest, Darryn Knobel, Rudovick R. Kazwala, Daniel T. Haydon, et Sarah Cleaveland. «The Feasibility of Canine Rabies Elimination in Africa: Dispelling Doubts with Data». Édité par Charles E. Rupprecht. PLoS Neglected Tropical Diseases 4, no 2 (23 février 2010): e626. https://doi.org/10.1371/journal.pntd.0000626.
  31. Freuling, Conrad M., Katie Hampson, Thomas Selhorst, Ronald Schröder, Francois X. Meslin, Thomas C. Mettenleiter, et Thomas Müller. «The Elimination of Fox Rabies from Europe: Determinants of Success and Lessons for the Future». Philosophical Transactions of the Royal Society B: Biological Sciences 368, no 1623 (5 août 2013): 20120142. https://doi.org/10.1098/rstb.2012.0142.
  32. Alkan, Cigdem, Eduardo Jurado-Cobena, et Tetsuro Ikegami. «Advancements in Rift Valley Fever Vaccines: A Historical Overview and Prospects for next Generation Candidates». Npj Vaccines 8, no 1 (4 novembre 2023). https://doi.org/10.1038/s41541-023-00769-w.
  33. Warimwe, George M., Joseph Gesharisha, B. Veronica Carr, Simeon Otieno, Kennedy Otingah, Danny Wright, Bryan Charleston, et al. «Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever». Scientific Reports 6, no 1 (5 février 2016). https://doi.org/10.1038/srep20617.
  34. Jenkin, Daniel, Daniel Wright, Pedro M Folegatti, Abigail Platt, Ian Poulton, Alison Lawrie, Nguyen Tran, et al. «Safety and Immunogenicity of a ChAdOx1 Vaccine against Rift Valley Fever in UK Adults: An Open-Label, Non-Randomised, First-in-Human Phase 1 Clinical Trial». The Lancet Infectious Diseases 23, no 8 (août 2023): 956-64. https://doi.org/10.1016/s1473-3099(23)00068-3.
  35. Warimwe, George M., Michael J. Francis, Thomas A. Bowden, Samuel M. Thumbi, et Bryan Charleston. «Using Cross-Species Vaccination Approaches to Counter Emerging Infectious Diseases». Nature Reviews Immunology 21, no 12 (décembre 2021): 815-22. https://doi.org/10.1038/s41577-021-00567-2.
  36. Wirblich, Christoph, Christopher M. Coleman, Drishya Kurup, Tara S. Abraham, John G. Bernbaum, Peter B. Jahrling, Lisa E. Hensley, Reed F. Johnson, Matthew B. Frieman, et Matthias J. Schnell. «One-Health: A Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus». Édité par Adolfo García-Sastre. Journal of Virology 91, no 2 (15 janvier 2017): e02040-16. https://doi.org/10.1128/JVI.02040-16.
  37. https://cwhl.vet.cornell.edu/article/wildlife-vaccination-growing-feasibility
  38. Fausther-Bovendo, Hugues, Sabue Mulangu, et Nancy J Sullivan. «Ebolavirus Vaccines for Humans and Apes». Current Opinion in Virology 2, no 3 (juin 2012): 324-29. https://doi.org/10.1016/j.coviro.2012.04.003.
  39. Barnett, K.M., et David J. Civitello. «Ecological and Evolutionary Challenges for Wildlife Vaccination». Trends in Parasitology 36, no 12 (décembre 2020): 970-78. https://doi.org/10.1016/j.pt.2020.08.006.
  40. Mansouri, Ahlem, Mickael Cregut, Chiraz Abbes, Marie-Jose Durand, Ahmed Landoulsi, et Gerald Thouand. «The Environmental Issues of DDT Pollution and Bioremediation: A Multidisciplinary Review». Applied Biochemistry and Biotechnology 181, no 1 (janvier 2017): 309-39. https://doi.org/10.1007/s12010-016-2214-5.
  41. De La Fuente, José, et Agustín Estrada-Peña. «Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?» Vaccines 7, no 3 (28 juillet 2019): 75. https://doi.org/10.3390/vaccines7030075.
  42. Gonçalves, Daniel, et Patrick Hunziker. «Transmission-Blocking Strategies: The Roadmap from Laboratory Bench to the Community». Malaria Journal 15, no 1 (décembre 2016): 95. https://doi.org/10.1186/s12936-016-1163-3.
  43. Ojha, Rupal, Rajan Kumar Pandey, et Vijay Kumar Prajapati. «Vaccinomics Strategy to Concoct a Promising Subunit Vaccine for Visceral Leishmaniasis Targeting Sandfly and Leishmania Antigens». International Journal of Biological Macromolecules 156 (août 2020): 548-57. https://doi.org/10.1016/j.ijbiomac.2020.04.097.
  44. Cebrián-Camisón S, Martínez-de la Puente J, et Figuerola J «A Literature Review of Host Feeding Patterns of Invasive Aedes Mosquitoes in Europe» Insects 2020 Nov 29;11(12):848. doi: 10.3390/insects11120848.
  45. Heilmann KP, Rice CL, Miller AL et al «Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States». Antimicrob Agents Chemother 2005 Jun;49(6):2561-4.doi: 10.1128/AAC.49.6.2561-2564.2005.
  46. Jansen K , Knirsch C, Anderson AL «The role of vaccines in preventing bacterial antimicrobial resistance» Nat Medicine, 2018 Jan 9;24(1):10-19. doi: 10.1038/nm.4465.
  47. Micoli F, Bagnoli F, Rappuoli R, Serruto D «The role of vaccines in combatting antimicrobial resistance» Nat Rev Microbiol, 2021 May;19(5):287-302. doi: 10.1038/s41579-020-00506-3..
  48. https://www.woah.org/app/uploads/2021/09/ahg-amur-vaccines-ruminants-may2018.pdf
  49. Pereira V, Zurita-Turk M, Saraiva T et al «DNA Vaccines Approach: From Concepts to Applications» World Journal of Vaccines (2014) 04(02) 50-71 doi: 10.4236/wjv.2014.42008
  50. Draper S & Heeney J «Viruses as vaccine vectors for infectious diseases and cancer» Nat Rev Microbiol, 2010 Jan;8(1):62-73. doi: 10.1038/nrmicro2240.
  51. https://www.has-sante.fr/jcms/p_3221567/fr/aspects-immunologiques-et-virologiques-de-l-infection-par-le-sars-cov-2
  52. Thoms F, Haas S, Erhart A et al, «Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of Owners» Viruses, 2020 Mar 6;12(3):288. doi: 10.3390/v12030288.

Dans la même catégorie - Maladies émergentes